Field safety notices: Helena Biosciences Europe
Manufacturer registered in EUDAMED: SRN GB-MF-000028365 ; country: United Kingdom
7 authority publications by 3 authorities, from 14 Dec 2020 to 16 Nov 2026.
Latest notice: 16 Nov 2026, AEMPS, V8 UltraCE, referencia V801
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Helena Biosciences Europe or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
5 distinct corrective actions.
Corrective action: 3 publications by AEMPS, ANSM, BfArM, from 6 Nov 2026 to 16 Nov 2026
- V8 UltraCE, referencia V801Models, lots, UDI: UDI-DI: 05056013025689
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- Automate V8 UltraCE
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- BfArMGermanyofficial source: V8 UltraCE, BfArM, 2026-11-06V8 UltraCE
Source: BfArM – Safety instructions in the field · collected 16 Nov 2026
- Réactif Thromboplastin L, PT
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Automate V8 Nexus
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Reactivos HEMOS PTT referencias GN1030 y GN1033
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- Reactivos HEMOS PTT referencias GN1030 y GN1033
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026